184 related articles for article (PubMed ID: 37332118)
1. Molecular features, biological behaviors and clinical implications of m
Zhan M; Song H; Tian D; Wen Q; Shi X; Wang Y; Mao X; Wang J
Cancer Biol Ther; 2023 Dec; 24(1):2223382. PubMed ID: 37332118
[TBL] [Abstract][Full Text] [Related]
2. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
4. RNA m
Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
Front Immunol; 2022; 13():905057. PubMed ID: 36389669
[TBL] [Abstract][Full Text] [Related]
5. RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.
Yang S; Luo Y; Zhou D; Xiang J; Xi X
Transl Cancer Res; 2023 Oct; 12(10):2556-2571. PubMed ID: 37969377
[TBL] [Abstract][Full Text] [Related]
6. The hub ten gene-based risk score system using RNA m
Yuan B; Liu W; Huo M; Zhang J; Yang Y; Gao T; Yin X; Yang T; Teng X; Huang W; Yu H
Breast Cancer; 2022 Jul; 29(4):645-658. PubMed ID: 35174450
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of m
Miao Y; Su B; Tang X; Wang J; Quan W; Chen Y; Mi D
IET Syst Biol; 2022 Apr; 16(2):59-71. PubMed ID: 35174637
[TBL] [Abstract][Full Text] [Related]
8. The Identification of Critical m
Xu J; Liu Y; Liu J; Xu T; Cheng G; Shou Y; Tong J; Liu L; Zhou L; Xiao W; Xiong Z; Yuan C; Chen Z; Liu D; Yang H; Liang H; Chen K; Zhang X
Front Genet; 2020; 11():602485. PubMed ID: 33343639
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
Front Immunol; 2021; 12():769425. PubMed ID: 34804059
[TBL] [Abstract][Full Text] [Related]
10. Role of m
Fang X; Miao C; Zeng T; Chu W; Zheng Y; Sun X; Yin X; Li Y
J Clin Lab Anal; 2022 Apr; 36(4):e24303. PubMed ID: 35212022
[TBL] [Abstract][Full Text] [Related]
11. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
[TBL] [Abstract][Full Text] [Related]
12. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
13. Comprehensive Analysis of 5-Methylcytosine (m
Wang R; Guo Y; Ma P; Song Y; Min J; Zhao T; Hua L; Zhang C; Yang C; Shi J; Zhu L; Gan D; Li S; Li J; Su H
Front Oncol; 2022; 12():851766. PubMed ID: 35433474
[TBL] [Abstract][Full Text] [Related]
14. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the Role of m
Wei Q; Yang D; Liu X; Zhao H; Yang Y; Xu J; Liu T; Yi P
Front Genet; 2021; 12():650554. PubMed ID: 34149801
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
17. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
18. Identification and construction of a prognostic risk model based on multi-RNA methylation regulators in cervical cancer.
Yan X; Qu Y; Huang W; Zhang H; Zhu L; Zhang L
J Obstet Gynaecol Res; 2022 Dec; 48(12):3199-3208. PubMed ID: 36101016
[TBL] [Abstract][Full Text] [Related]
19. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of N6-Methyladenosine (m
Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]